Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.80 -0.88 (-3.30%)
As of: Sep 30, 2026 · 3:59 PM EDT

Amphastar Pharmaceuticals (AMPH) Free Cash Flow (2013 - 2026)

Updated

Amphastar Pharmaceuticals' Free Cash Flow came in at $42.73 million for Q2 2026, up 70.7% from $25.03 million a year earlier and up 11.5% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Free Cash Flow (2013 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Amphastar Pharmaceuticals reported Free Cash Flow of $152.89 million, up 36.3% year-over-year; for FY2025, it came in at $121.23 million, down 29.7% from FY2024.

  • Free Cash Flow carries a five-year compound annual growth rate of 38.9% (FY2020 to FY2025).
  • Going back by year, Free Cash Flow was $172.35 million in FY2024 (+18.6%), $145.34 million in FY2023 (+123.1%), $65.15 million in FY2022 (-7.6%) and $70.54 million in FY2021 (+201.3%).
  • The five-year range for quarterly Free Cash Flow is -$4.65 million (Q3 2021) to $63.07 million (Q2 2024).
  • Year-over-year, Free Cash Flow has increased for four consecutive quarters, with growth averaging 8.9% over the last eight quarters.
  • The fastest year-over-year change in Free Cash Flow over five years came in Q4 2021 (growth of 343.7%), and the weakest in Q4 2022 (a decline of 73.4%).
  • Business Quant data shows AMPH's Free Cash Flow at $38.33 million (Q1 2026), $24.59 million (Q4 2025) and $47.24 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 7.30 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 3.11 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 5.34 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 3.43 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.01 Bn
10 Amphastar Pharmaceuticals 1.13 Bn -6.34 Mn 93.47 Mn 42.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.73 Mn
Mar 31, 2026 38.33 Mn
Dec 31, 2025 24.59 Mn
Sep 30, 2025 47.24 Mn
Jun 30, 2025 25.03 Mn
Mar 31, 2025 24.38 Mn
Dec 31, 2024 16.61 Mn
Sep 30, 2024 46.17 Mn
Jun 30, 2024 63.07 Mn
Mar 31, 2024 46.50 Mn
Dec 31, 2023 14.42 Mn
Sep 30, 2023 54.14 Mn
Jun 30, 2023 45.87 Mn
Mar 31, 2023 30.91 Mn
Dec 31, 2022 8.92 Mn
Sep 30, 2022 14.75 Mn
Jun 30, 2022 -3.15 Mn
Mar 31, 2022 44.63 Mn
Dec 31, 2021 33.56 Mn
Sep 30, 2021 -4.65 Mn
API Access

Amphastar Pharmaceuticals Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=AMPH&period=max&api_key=YOUR_API_KEY